Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Cl.O.Sb |
| Molecular Weight | 173.212 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[O--].[Cl-].[Sb+3]
InChI
InChIKey=LIRSFCJKZQBJRK-UHFFFAOYSA-M
InChI=1S/ClH.O.Sb/h1H;;/q;-2;+3/p-1
| Molecular Formula | HO |
| Molecular Weight | 17.0073 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Sb |
| Molecular Weight | 121.76 |
| Charge | 3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.whocc.no/atcvet/atcvet_index/?code=QR05CA07https://www.ncbi.nlm.nih.gov/pubmed/5295139 | https://www.ncbi.nlm.nih.gov/pubmed/14851220 | https://www.ncbi.nlm.nih.gov/pubmed/8898332Curator's Comment: description was created based on several sources, including https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ef48d40-6d63-440b-a73c-46d89f425936
Sources: https://www.whocc.no/atcvet/atcvet_index/?code=QR05CA07https://www.ncbi.nlm.nih.gov/pubmed/5295139 | https://www.ncbi.nlm.nih.gov/pubmed/14851220 | https://www.ncbi.nlm.nih.gov/pubmed/8898332
Curator's Comment: description was created based on several sources, including https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ef48d40-6d63-440b-a73c-46d89f425936
Stibophen (Fuadin), an organic trivalent antimony compound, has been used for many years in the treatment of schistosomiasis. Stibophen is used as treatment of schistosomiasis by intramuscular injection. Stibophen is known to act by selectively inhibiting worm PFK.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 17 00:58:08 UTC 2022
by
admin
on
Sat Dec 17 00:58:08 UTC 2022
|
| Record UNII |
Y7P96CY2ZK
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
7791-08-4
Created by
admin on Sat Dec 17 00:58:08 UTC 2022 , Edited by admin on Sat Dec 17 00:58:08 UTC 2022
|
PRIMARY | |||
|
9793982
Created by
admin on Sat Dec 17 00:58:08 UTC 2022 , Edited by admin on Sat Dec 17 00:58:08 UTC 2022
|
PRIMARY | |||
|
DTXSID0064880
Created by
admin on Sat Dec 17 00:58:08 UTC 2022 , Edited by admin on Sat Dec 17 00:58:08 UTC 2022
|
PRIMARY | |||
|
Y7P96CY2ZK
Created by
admin on Sat Dec 17 00:58:08 UTC 2022 , Edited by admin on Sat Dec 17 00:58:08 UTC 2022
|
PRIMARY | |||
|
Antimony oxychloride
Created by
admin on Sat Dec 17 00:58:08 UTC 2022 , Edited by admin on Sat Dec 17 00:58:08 UTC 2022
|
PRIMARY | |||
|
M1954
Created by
admin on Sat Dec 17 00:58:08 UTC 2022 , Edited by admin on Sat Dec 17 00:58:08 UTC 2022
|
PRIMARY | Merck Index | ||
|
232-238-8
Created by
admin on Sat Dec 17 00:58:08 UTC 2022 , Edited by admin on Sat Dec 17 00:58:08 UTC 2022
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
